Focused on Innovation

ITUS Corporation funds, develops, acquires, and licenses emerging technologies in areas such as biotechnology. The Company’s wholly owned subsidiary, Anixa Diagnostics Corporation, is developing a platform called Cchek™, a series of non-invasive, blood tests for the early detection of solid tumor based cancers.

Learn More

ITUS in the News

In this Fox News segment, Dr. Manny Alvaraez discusses Cancer4Pres.org and Cchek™ with Rob Berman, CEO & President of ITUS Corporation.

Itus In The News

Anixa Diagnostics

Anixa Diagnostics, a subsidiary of ITUS Corporation, is developing a platform for inexpensive, non-invasive cancer screening blood tests for the early detection of tumor based cancers.

Learn More
NASDAQ ITUS
Price
Change
Volume
Day Range
52 Wk Range

Sign Up for Email Updates

Be the first to receive the breaking news

Sign Up